ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

MDC Mediclinic International Plc

501.00
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Mediclinic International Plc LSE:MDC London Ordinary Share GB00B8HX8Z88 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 501.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Mediclinic International PLC Director/PDMR Shareholding (9894Q)

05/12/2016 1:30pm

UK Regulatory


Mediclinic (LSE:MDC)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Mediclinic Charts.

TIDMMDC

RNS Number : 9894Q

Mediclinic International PLC

05 December 2016

Mediclinic International PLC (the "Company")

(Incorporated in England and Wales)

Company Number: 08338604

LSE Share Code: MDC

JSE Share Code: MEI

NSX Share Code: MEP

ISIN: GB00B8HX8Z88

5 December 2016

NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

Mediclinic announces that on 5 December 2016 Dr Edwin Hertzog, Chairman of the Company, transferred an aggregate of 3,360,579 ordinary shares of 10 pence each in the capital of the Company from Elstelm Beleggings (Pty) Ltd to entities controlled by his children with effect from 1 December 2016. Following the transfer, the aggregate beneficial interest of Dr Hertzog and his family remains unchanged at 3,754,855, representing 0.51% of the Company's issued share capital.

The notifications below, which have been made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail

 
 1.   Details of PDMR / person closely associated 
       with them ("PCA") 
---  --------------------------------------------------------- 
 a)   Name                   Elstelm Beleggings (Pty) Ltd 
---  ---------------------  ---------------------------------- 
 2.   Reason for the notification 
---  --------------------------------------------------------- 
 a)   Position               Investment company of Dr Edwin 
       / status               Hertzog, Chairman of the Company 
---  ---------------------  ---------------------------------- 
 b)   Initial notification   Initial Notification 
       / amendment 
---  ---------------------  ---------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  --------------------------------------------------------- 
 a)   Name                   Mediclinic International plc 
---  ---------------------  ---------------------------------- 
 b)   LEI                    N/A 
---  ---------------------  ---------------------------------- 
 4.   Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  --------------------------------------------------------- 
 a)   Description            Ordinary Shares 
       of the financial 
       instrument 
                              GB00B8HX8Z88 
       Identification 
       Code 
---  ---------------------  ---------------------------------- 
 b)   Nature of              Transfer of shares 
       the transaction 
---  ---------------------  ---------------------------------- 
 c)   Price(s)                Price(s)              Volume(s) 
       and volume(s)          --------------------  ---------- 
                               ZAR 419 064 201.30    3,360,579 
                              --------------------  ---------- 
---  ---------------------  ---------------------------------- 
 d)   Aggregated 
       information 
 
       Aggregated              3,360,579 
       volume 
                               ZAR 124.70 per share 
       Price 
---  ---------------------  ---------------------------------- 
 e)   Date of the            5 December 2016 
       transaction 
---  ---------------------  ---------------------------------- 
 f)   Place of               Johannesburg Stock Exchange 
       the transaction 
---  ---------------------  ---------------------------------- 
 

Registered address: 1(st) Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom

Website: www.mediclinic.com

JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Ltd

For further information please contact:

Mediclinic International plc

James Arnold, Head of Investor Relations

ir@mediclinic.com

Capita Company Secretarial Services Limited

Victoria Dalby

+44 (0)207 954 9600

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBXBDDSGGBGLU

(END) Dow Jones Newswires

December 05, 2016 08:30 ET (13:30 GMT)

1 Year Mediclinic Chart

1 Year Mediclinic Chart

1 Month Mediclinic Chart

1 Month Mediclinic Chart

Your Recent History

Delayed Upgrade Clock